Home > Boards > US Listed > Biotechs > Clovis Oncology, Inc. (CLVS)

My investment in Clovis is now worth less

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
Clovis Oncology to Announce Second Quarter 2021 Financial Results and Host Webcast Conference Call on August 4 Business Wire - 7/21/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/13/2021 4:26:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2021 8:10:52 AM
Clovis Oncology adds Ronit Simantov to board of directors Seeking Alpha - 7/12/2021 4:15:39 PM
Clovis Oncology Appoints Dr. Ronit Simantov to its Board of Directors Business Wire - 7/12/2021 4:05:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/6/2021 4:16:38 PM
Initial Clinical Experience of FAP-2286 in Independent Named Patient Use Published in The Journal of Nuclear Medicine Business Wire - 6/28/2021 7:00:00 AM
Senseonics and Clovis Oncology gain ahead of inclusion in Russell Indexes Seeking Alpha - 6/25/2021 2:07:36 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/23/2021 4:31:45 PM
Clovis starts enrollment of phase 1/2 trial for candidate to treat tumors Seeking Alpha - 6/23/2021 7:39:39 AM
Clovis Oncology Announces LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy FAP-2286 Now Open for... Business Wire - 6/23/2021 7:00:00 AM
Clovis Oncology gain attributed to a policy bulletin issued by Aetna Seeking Alpha - 6/14/2021 10:14:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2021 4:39:54 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/10/2021 4:36:15 PM
Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders Business Wire - 6/10/2021 4:30:00 PM
Clovis Oncology and Inovio gain amid Reddit chatter Seeking Alpha - 6/9/2021 11:17:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:03:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:01:58 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 7:01:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 6:59:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2021 6:58:23 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/28/2021 5:02:05 PM
Clovis Oncology Highlights Rubraca® (rucaparib) and Lucitanib Data at 2021 ASCO Annual Meeting Business Wire - 5/19/2021 6:27:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/17/2021 4:40:53 PM
Clovis Oncology launches $75M at-the-market equity offering program Seeking Alpha - 5/17/2021 4:25:17 PM
shub   Friday, 01/18/19 02:55:53 PM
Re: Country Squire post# 212
Post # of 683 
My investment in Clovis is now worth less than 1/4 of what i put in.
CLVS IP is worth much less than before and faith in management has been blown away.There is some chance the pipeline will save us, but it's not great.
Wishing for a buy out is grasping at straws.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences